Both in Pharmaceuticals
Generate Biomedicines vs Agios Pharmaceuticals
Over the past year GENB returned −9.9% and AGIO returned −6.6%; their daily moves had a correlation of 0.51.
GENB −9.9% AGIO −6.6%Growth of $1, one year, split-adjusted
| Metric | GENB | AGIO |
|---|---|---|
| Price | $14.16 | $31.38 |
| Market cap | $1.82B | $1.87B |
| Today | +2.24% | +0.58% |
| 1 month | +2.6% | −1.1% |
| 6 months | — | +16.3% |
| Year to date | — | +15.3% |
| 1 year | — | −21.8% |
| Revenue growth (YoY) | — | +259.3% |
| Gross margin | 100.0% | 93.3% |
| Net margin | −1065.2% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.1× |
| Net cash | $452.3M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 58.0% |
| Short % of float | 15.4% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).